![]() |
产地 | 中国 |
品牌 | 爱必信(absin) |
货号 | abs814873 |
用途 | 见爱必信官网 |
英文名称 | 见爱必信官网 |
包装规格 | 10mg,10mg,25mg,25mg,100mg,100mg |
纯度 | ≥98%% |
CAS编号 | 138977-28-3 |
别名 | 辣椒平 |
是否进口 | 否 |
公告提醒:爱必信所有产品和服务仅用于科学研究,不用于临床应用及其他用途提供产品和服务(也不为任何个人提供产品和服务)!
抑制剂描述: 产品名称:Capsazepine 产品别名:见爱必信官网 英文别名:Capsazepine 靶点:TRP Channel CAS:138977-28-3 纯度:≥98% 外观:见爱必信官网 保存方法:Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. 描述: Capsazepine acts as a competitive antagonist of capsaicin and a transient receptor potential vanilloid type 1(TRPV1) antagonist. 溶解性:DMSO : ≥ 50 mg/mL (132.66 mM) 体外研究:
Capsazepine(CPZ) at a concentration of 94.2 μg/ml (IC50 concentration of capsazepine) exhibits a statistically significant inhibition of osteoclast growth and proliferation. Capsazepine converts the NKA into Na-ATPase. CPZ inhibits K+-dependent activity but allows Na-ATPase associated with Na+ transport. CPZ has no effect on Na-ATPase measured in the absence of K+. CPZ also inhibits para-nitrophenyl phosphatase activity, albeit with a lower affinity. CPZ strongly reduces the steady-state EP level and the Na+ affinity for phosphorylation decreased 3-fold after CPZ treatment. In summary, CPZ blocks an Na+/K+ cycle in the NKA but leaves an Na+ cycle intact, reducing the transport stoichiometry of the pump. Capsazepine inhibits osteoclast formation and bone resorption in a dose dependent manner in bone marrow-osteoblast co-cultures and RANKL generated osteoclast cultures. Capsazepine also suppresses RANKL induced IκB and ERK1/2 phosphorylation and causes apoptosis of mature osteoclasts and also inhibits alkaline phosphatase activity and bone nodule formation in calvarial osteoblast cultures. 体内研究:In mice, the TRPV1 antagonist capsazepine blocks morphine tolerance and dependence in mice. Acute capsazepine treatment (5 mg/kg, i.p.) potentiates the antinociceptive effects of morphine, as measured by the hot-plate test. Repeated co-treatment of capsazepine (2.5 mg/kg, i.p.) with morphine attenuates the development of tolerance to the antinociceptive effect of morphine. The development of morphine dependence is also reduced by capsazepine (1.25 or 2.5 mg/kg, i.p.). Capsazepine (1 mg/kg/day) inhibits ovariectomy induced bone loss in mice and histomorphometric analysis shows inhibitory effects on indices of bone resorption and bone formation.
产品信息订购:
|